array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Becton, Dickinson and Company" ["slug"]=> string(37) "4601d-us-becton-dickinson-and-company" ["logo"]=> NULL ["description"]=> NULL ["address_street"]=> string(11) "1 Becton Dr" ["address_place"]=> string(14) "Franklin Lakes" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1897-02-28" ["website_domain"]=> string(6) "bd.com" ["website_url"]=> string(18) "https://www.bd.com" ["industry_codes"]=> array(2) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" [1]=> string(60) "Orthopedic, Prosthetic, and Surgical Appliances and Supplies" } ["employee_count"]=> int(1500) ["article_count"]=> int(417) } ["articles"]=> array(8) { [0]=> array(7) { ["title_en"]=> string(98) "Becton, Dickinson and Company Appoints Greg Rodetis as Senior Vice President of Investor Relations" ["snippet_en"]=> string(63) "Rodetis will also continue to serve as the company's treasurer." ["url"]=> string(128) "https://www.pharmexec.com/view/becton-dickinson-and-company-appoints-greg-rodetis-as-senior-vice-president-of-investor-relations" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c8ebba55-7f95-45e5-8428-c18f1292d4de" ["source"]=> string(13) "pharmexec.com" ["publication_date"]=> string(10) "2023-10-17" ["categories"]=> array(2) { [0]=> string(12) "Staff hiring" [1]=> string(12) "Board Change" } } [1]=> array(7) { ["title_en"]=> string(70) "BD Appoints Owens & Minor HR Leader Shana Neal as Chief People Officer" ["snippet_en"]=> string(54) "Neal held HR leadership roles at BD from 2005 to 2018." ["url"]=> string(132) "https://www.mpo-mag.com/contents/view_breaking-news/2022-02-24/bd-appoints-owens-minor-hr-leader-shana-neal-as-chief-people-officer/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9a0256e6-3dd6-4e56-a136-c20ea0ca2991" ["source"]=> string(11) "mpo-mag.com" ["publication_date"]=> string(10) "2022-02-24" ["categories"]=> array(3) { [0]=> string(24) "Access and affordability" [1]=> string(12) "Board Change" [2]=> string(12) "Staff hiring" } } [2]=> array(7) { ["title_en"]=> string(50) "BD Names Dr. Carrie Byington To Board Of Directors" ["snippet_en"]=> string(159) "/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has..." ["url"]=> string(105) "https://www.prnewswire.com/news-releases/bd-names-dr-carrie-byington-to-board-of-directors-301406422.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/35d16d54-6891-48da-9378-9c37bbaa2296" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2021-10-22" ["categories"]=> array(1) { [0]=> string(12) "Board Change" } } [3]=> array(7) { ["title_en"]=> string(78) "David Albritton selected to join the board of directors of Embecta Corporation" ["snippet_en"]=> string(291) "Global medical technology company, Becton, Dickinson and Company (BD), has announced that Embecta Corp. will hold BD's Diabetes Care business upon completion of the spinoff, and will be governed by a nine-person board of directors. Once constituted, the board is expected to include David J." ["url"]=> string(117) "https://www.blackengineer.com/article/david-albritton-selected-to-join-the-board-of-directors-of-embecta-corporation/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c7fa3520-c454-4600-8423-c1abf9a2431b" ["source"]=> string(17) "blackengineer.com" ["publication_date"]=> string(10) "2020-02-14" ["categories"]=> array(3) { [0]=> string(8) "spin-off" [1]=> string(12) "Board Change" [2]=> string(20) "Corporate Governance" } } [4]=> array(7) { ["title_en"]=> string(51) "Claire Pomeroy Joins Haemonetics Board of Directors" ["snippet_en"]=> string(162) "/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Claire Pomeroy, M.D., MBA, to its Board of Directors. Dr. Pomeroy is President of..." ["url"]=> string(107) "https://www.prnewswire.com/news-releases/claire-pomeroy-joins-haemonetics-board-of-directors-300839902.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/0a0d9815-57a2-4b83-b983-4a3b6132a579" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2019-04-29" ["categories"]=> array(1) { [0]=> string(12) "Board Change" } } [5]=> array(7) { ["title_en"]=> string(57) "Boston Scientific Announces Changes to Board of Directors" ["snippet_en"]=> string(161) "/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today a number of changes to the leadership and membership of its Board of Directors. Pete..." ["url"]=> string(113) "https://www.prnewswire.com/news-releases/boston-scientific-announces-changes-to-board-of-directors-300225953.html" ["image_url"]=> NULL ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2016-02-25" ["categories"]=> array(2) { [0]=> string(12) "Board Change" [1]=> string(25) "Leadership and Governance" } } [6]=> array(7) { ["title_en"]=> string(68) "Enable Injections Enhances Board With Addition Of John DeFord, Ph.D." ["snippet_en"]=> string(276) "Enable Injections, Inc. (“Enable”), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce the appointment of John DeFord, Ph.D. to the company’s Board of Directors, effective July 29, 2022." ["url"]=> string(112) "https://www.pharmaceuticalonline.com/doc/enable-injections-enhances-board-with-addition-of-john-deford-ph-d-0001" ["image_url"]=> string(78) "https://images.businessradar.com/articles/39134401-7f95-4237-b028-fcd61faef524" ["source"]=> string(24) "pharmaceuticalonline.com" ["publication_date"]=> NULL ["categories"]=> array(5) { [0]=> string(5) "R & D" [1]=> string(12) "Staff hiring" [2]=> string(12) "Board Change" [3]=> string(20) "Corporate Governance" [4]=> string(10) "Executives" } } [7]=> array(7) { ["title_en"]=> string(45) "Zimmer Biomet Announces Leadership Transition" ["snippet_en"]=> string(294) "WARSAW, Ind., Aug. 22, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced the appointment of Ivan Tornos as President and Chief Executive Officer (CEO) and election to the Board of Directors, effective immediately. Mr. Tornos has most recently served as Chief" ["url"]=> string(106) "https://www.morningstar.com/news/pr-newswire/20230822de89693/zimmer-biomet-announces-leadership-transition" ["image_url"]=> NULL ["source"]=> string(15) "morningstar.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(12) "Board Change" [1]=> string(10) "Executives" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(44) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [3]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(20) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(20) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(15) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(13) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(12) } [12]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(8) } [16]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(14) "Product Recall" ["count"]=> int(6) } [20]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(6) } [21]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [22]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(5) } [23]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(5) } [24]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [25]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(4) } [26]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(4) } [27]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(4) } [28]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(4) } [29]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(4) } } } 4601d-us-becton-dickinson-and-company